Literature DB >> 3039500

Expression and nuclear envelope localization of biologically active fusion glycoprotein gB of herpes simplex virus in mammalian cells using cloned DNA.

M A Ali, M Butcher, H P Ghosh.   

Abstract

Herpes simplex virus (HSV) is known to bud from the inner membrane of the nuclear envelope. The structural gene for the glycoprotein gB, which is essential for virus entry and cell fusion induced by HSV type 1, has been cloned in a transient expression vector containing the adenovirus major late promoter, tripartite leader sequence, and VARNA (a special RNA in adenovirus-infected cells) genes. Synthesis and glycosylation of glycoprotein gB was observed in COS-1 cells transfected with the vector containing the gB gene. Removal of a 3' fragment of the cloned gene resulted in the synthesis and secretion of a truncated gB glycoprotein. Immunofluorescence studies revealed that the expressed glycoprotein was localized in the nuclear envelope as well as in the cell surface. The expressed gB-1 glycoprotein was biologically active and induced fusion of cells to produce polykaryons. These data show that HSV glycoprotein gB expressed from cloned gene can be used as a model to study targeting of proteins into the nuclear envelope as well as cell fusion induced by the virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039500      PMCID: PMC298925          DOI: 10.1073/pnas.84.16.5675

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity.

Authors:  M Sarmiento; M Haffey; P G Spear
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

2.  Structural analysis of precursor and product forms of type-common envelope glycoprotein D (CP-1 antigen) of herpes simplex virus type 1.

Authors:  R J Eisenberg; C Hydrean-Stern; G H Cohen
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

3.  Herpesvirus envelopment.

Authors:  R W Darlington; L H Moss
Journal:  J Virol       Date:  1968-01       Impact factor: 5.103

4.  Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4.

Authors:  S D Showalter; M Zweig; B Hampar
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

5.  A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1.

Authors:  S P Little; J T Jofre; R J Courtney; P A Schaffer
Journal:  Virology       Date:  1981-11       Impact factor: 3.616

6.  Nucleotide sequences of herpes simplex virus type 1 (HSV-1) affecting virus entry, cell fusion, and production of glycoprotein gb (VP7).

Authors:  N DeLuca; D J Bzik; V C Bond; S Person; W Snipes
Journal:  Virology       Date:  1982-10-30       Impact factor: 3.616

Review 7.  Using recombinant DNA techniques to study protein targeting in the eucaryotic cell.

Authors:  H Garoff
Journal:  Annu Rev Cell Biol       Date:  1985

8.  Synthesis and maturation of glycoproteins of enveloped animal viruses.

Authors:  H P Ghosh
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

Review 9.  The nuclear envelope and the architecture of the nuclear periphery.

Authors:  W W Franke; U Scheer; G Krohne; E D Jarasch
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

10.  Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses.

Authors:  J White; K Matlin; A Helenius
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

View more
  22 in total

1.  Overexpression in bacterial and identification in infected cells of the pseudorabies virus protein homologous to herpes simplex virus type 1 ICP18.5.

Authors:  N E Pederson; L W Enquist
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.

Authors:  M A Ali; D McWeeney; A Milosavljevic; J Jurka; R J Jariwalla
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Low pH-induced conformational change in herpes simplex virus glycoprotein B.

Authors:  Stephen J Dollery; Mark G Delboy; Anthony V Nicola
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

4.  Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration.

Authors:  A O Fuller; R E Santos; P G Spear
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.

Authors:  S L Highlander; W H Cai; S Person; M Levine; J C Glorioso
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  Intracellular compartmentalization of the glycoprotein B of herpesvirus Simian agent 8 expressed with a baculovirus vector in insect cells.

Authors:  M Veit; E Ponimaskin; S Baiborodin; H R Gelderblom; M F Schmidt
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Resolving the assembly state of herpes simplex virus during axon transport by live-cell imaging.

Authors:  Sarah E Antinone; Sofia V Zaichick; Gregory A Smith
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

8.  Effects of deletions in the carboxy-terminal hydrophobic region of herpes simplex virus glycoprotein gB on intracellular transport and membrane anchoring.

Authors:  L Rasile; K Ghosh; K Raviprakash; H P Ghosh
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

9.  Intra-nuclear localization of two envelope proteins, gB and gD, of herpes simplex virus.

Authors:  L M Stannard; S Himmelhoch; S Wynchank
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment.

Authors:  S Keay; B Baldwin
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.